Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...
On June 16, 2026, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule that would codify the Medicare Drug Price ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
On July 6th, Sen. Jim Banks (R-Ind.) sent a letter to Commerce Secretary Howard Lutnick urging the U.S. Patent and Trademark ...
Industry groups are asking the US Food and Drug Administration (FDA) for greater transparency into its Commissioner's National Priority Voucher (CNPV) pilot, including how the agency intends to ...
PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) , a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class ...
AVE has made a breakthrough with a phase III insomnia trial for its soft gel cannabidiol to manage sleeplessness. ... Read ...
TEMPO.CO, Jakarta - The Ministry of Health will bring in doctors from Belarus to train medical personnel in Indonesia. Both ...
Naming challenges, combination trials and AI augmentation are forcing pharma brands to establish strategic differentiation ...
Divis Laboratories benefits from strong CDMO demand but faces high valuations, prompting a hold recommendation for investors.
A successful closure of a US FDA inspection is generally viewed positively by investors as it removes a key regulatory ...
1d
BetterLife Pharma Announces Appointment of John W. LaRocca to Board of Directors and Audit Committee
Detailed price information for Betterlife Pharma Inc (BETR-CN) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results